Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shereen Ezzat

Showing results (211-220 of 249) with videos related to

Pageof 25
Sort By:
Clinical Endocrinology|November 2, 2007
A systematic review of the gonadal effects of therapeutic radioactive iodine in male thyroid cancer survivorsAnna M Sawka, Jane Lea, Bandar Alshehri, et al.
Journal of Surgical Oncology|April 30, 2013
Patients' experiences following local-regional recurrence of thyroid cancer: a qualitative studyShikha Misra, Soumia Meiyappan, Lineke Heus, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|March 1, 2008
Basis for physician recommendations for adjuvant radioiodine therapy in early-stage thyroid carcinoma: principal findings of the Canadian-American thyroid cancer surveyAnna M Sawka, David P Goldstein, Lehana Thabane, et al.
Trials|July 28, 2010
Decision aid on radioactive iodine treatment for early stage papillary thyroid cancer--a randomized controlled trialAnna M Sawka, Sharon Straus, James D Brierley, et al.
Thyroid : Official Journal of the American Thyroid Association|November 9, 2007
Regional differences in opinions on adjuvant radioactive iodine treatment of thyroid carcinoma within Canada and the United StatesAnna M Sawka, Lorne Rotstein, James D Brierley, et al.
Endocrine Pathology|December 6, 2024
Correction: Consensus Statement: Recommendations on Actionable Biomarker Testing for Thyroid Cancer ManagementOzgur Mete, Andrée Boucher, Kasmintan A Schrader, et al.
Endocrine Pathology|March 16, 2022
Overview of the 2022 WHO Classification of Neuroendocrine NeoplasmsGuido Rindi, Ozgur Mete, Silvia Uccella, et al.
Cancer Medicine|January 10, 2014
Hormone profiling, WHO 2010 grading, and AJCC/UICC staging in pancreatic neuroendocrine tumor behaviorEmilie Morin, Sonia Cheng, Ozgur Mete, et al.
Thyroid : Official Journal of the American Thyroid Association|September 27, 2012
The rationale of patients with early-stage papillary thyroid cancer for accepting or rejecting radioactive iodine remnant ablationAnna M Sawka, Heather Rilkoff, Richard W Tsang, et al.
Endocrine Pathology|November 23, 2024
Consensus Statement: Recommendations on Actionable Biomarker Testing for Thyroid Cancer ManagementOzgur Mete, Andrée Boucher, Kasmintan A Schrader, et al.
Pageof 25

Showing results (211-220 of 249) with videos related to

Sort By:
Pageof 25
Clinical Endocrinology|November 2, 2007
A systematic review of the gonadal effects of therapeutic radioactive iodine in male thyroid cancer survivorsAnna M Sawka, Jane Lea, Bandar Alshehri, et al.
Journal of Surgical Oncology|April 30, 2013
Patients' experiences following local-regional recurrence of thyroid cancer: a qualitative studyShikha Misra, Soumia Meiyappan, Lineke Heus, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|March 1, 2008
Basis for physician recommendations for adjuvant radioiodine therapy in early-stage thyroid carcinoma: principal findings of the Canadian-American thyroid cancer surveyAnna M Sawka, David P Goldstein, Lehana Thabane, et al.
Trials|July 28, 2010
Decision aid on radioactive iodine treatment for early stage papillary thyroid cancer--a randomized controlled trialAnna M Sawka, Sharon Straus, James D Brierley, et al.
Thyroid : Official Journal of the American Thyroid Association|November 9, 2007
Regional differences in opinions on adjuvant radioactive iodine treatment of thyroid carcinoma within Canada and the United StatesAnna M Sawka, Lorne Rotstein, James D Brierley, et al.
Endocrine Pathology|December 6, 2024
Correction: Consensus Statement: Recommendations on Actionable Biomarker Testing for Thyroid Cancer ManagementOzgur Mete, Andrée Boucher, Kasmintan A Schrader, et al.
Endocrine Pathology|March 16, 2022
Overview of the 2022 WHO Classification of Neuroendocrine NeoplasmsGuido Rindi, Ozgur Mete, Silvia Uccella, et al.
Cancer Medicine|January 10, 2014
Hormone profiling, WHO 2010 grading, and AJCC/UICC staging in pancreatic neuroendocrine tumor behaviorEmilie Morin, Sonia Cheng, Ozgur Mete, et al.
Thyroid : Official Journal of the American Thyroid Association|September 27, 2012
The rationale of patients with early-stage papillary thyroid cancer for accepting or rejecting radioactive iodine remnant ablationAnna M Sawka, Heather Rilkoff, Richard W Tsang, et al.
Endocrine Pathology|November 23, 2024
Consensus Statement: Recommendations on Actionable Biomarker Testing for Thyroid Cancer ManagementOzgur Mete, Andrée Boucher, Kasmintan A Schrader, et al.
Pageof 25